Related Experiment Video
Updated: Aug 26, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Complementary dose of COVID-19 vaccination may prevent SARS-CoV-2 breakthrough infection among previously vaccinated
Justyna D Kowalska1,2, Carlo Bieńkowski1, Ewa Firląg-Burkacka2
1Medical University of Warsaw, Department of Adults' Infectious Diseases.
Abstract:
People living with HIV (PLWH) are a heterogeneous group of immunocompromised persons. Detectable HIV viral load and chronic comorbidities are independently increasing the risk of severe outcomes from COVID-19 among PLWH. We aimed to assess the efficacy and safety of the COVID-19 vaccines in PLWH. A significant increase in S-RBD antibody titers >100 AU/mL was observed when compared the titers measured one week after the 1st dose to titers performed after the 2nd vaccine dose.
Related Concept Videos
Retrovirus Life Cycles
Vaccinations
Sexually Transmitted Infections
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Subviral Agents

